Using HeLa and Me-180 cell lines we showed that ATGL over-expression promoted cervical cancer cells proliferation demonstrating a pro-tumor feature of ATGL that was also observed in prostate cancer, pancreatic ductal adenocarcinoma, and breast cancer [31–33]. The gene discussed is PNPLA2; the disease is pancreatic ductal adenocarcinoma.